Association of serum C3 levels with the risk of myocardial infarction

The American Journal of Medicine

Volumn 98, Issue 4, 1995, Pages 357-364

  Muscari, Antonio ^a   Bozzoli, Claudio ^a   Puddu, Giovanni M ^a   Sangiorgi, Zina ^a   Dormi, Ada ^a,b   Rovinetti, Carlotta ^a,b   Descovich, Gian C ^a,b   Puddu, Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale SS Salvatore   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENT 3; COMPLEMENT 4; FEMALE; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; LOGISTIC MODELS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0028930107     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)80314-3     Document Type: Article

References (39)

1. Association of serum IgA and C4 with severe atherosclerosis
2. Complement and arteriosclerosis
3. The complement system in atherosclerosis
4. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
5. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque
6. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries
7. Membrane damage by complement Johns Hopkins
8. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a desArg
9. Immunoglobulin-bound lipoproteins (Ig-Lp) as markers of familial hypercholesterolemia, xanthomatosis and atherosclerosis
10. Association of serum IgA antibodies to milk antigens with severe atherosclerosis
11. Normative values of serum immunoglobulins by single radial immunodiffusion: a review
12. Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease
13. The Brisighella Study: a 6- year follow-up
14. The Brisighella Study
15. The Brisighella Heart Study: an interim report
16. Enzymatic determination of total serum cholesterol
17. Quantitative determination of serum triglycerides by the use of enzymes.
18. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions
19. Complement C3 in serum and plasma, as measured by radial immunodiffusion with four commercial kits
20. The influence of sample aging on the immunochemical quantification of complement components C3 and C4
21. Effect of aging of serum on quantitation of complement component C3
22. Association between coronary heart disease and the C3F-gene in essential hypertension
23. The susceptibility to insulindependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3.4 heterozygotes
24. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1,-C2, and-E and LDLR) and the genes C3, PEPD, and GPI
25. Complement component 3 (C3) genetics and diabetes mellitus
26. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolernic rabbits
27. Incremento dei livelli sierici di IgA e C4 nell'aterosclerosi: assenza di correlazione con il quadro arteriografico
28. Le syndrome inflammatoire et les modifications des proteines plasrnatiques
29. Coronary thrombosis: plaque rupture or acute inflammatory reaction?
30. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study
31. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction
32. The acute-phase reaction and haematological stress syndrome in vascular disease
33. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states
34. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to “risk factors” for myocardial infarction
35. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
36. The Brisighella heart study
37. Comparison of radial immunodiffusion and laser nephelometry for quantitating some serum proteins
38. Reference intervals for serum IgG, IgA, IgM, C3 and C4 as determined by rate nephelometry